HHS Secretary Alex Azar is "setting the world on fire," President Donald Trump said. Although Azar has signaled that drug prices are a priority, he’s not yet taken dramatic action on the subject. Meanwhile, an Illinois state lawmaker has introduced legislation intended to stop price-gouging on generic drugs.
from Kaiser Health News http://ift.tt/2Fp1kH0
February 23, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Shadowy Threesome Known As ‘Mar-A-Lago Crowd’ Have Been Silently Exerting Influence On Veterans AffairsThe Mar-a-Lago group is led by the reclusive chairman of Marvel Entertainment, Isaac Perlmutter, 75, a longtime friend of Mr. Trump’s and a member of his West Palm Beach golf club. Veterans advocates are worried that the grou… Read More
Jury Awards Man With Terminal Cancer $289M In Suit Against Company That Makes Weedkiller RoundupDewayne Johnson, 46, is a groundskeeper who used the products during his job. The jury found that Monsanto had failed to warn Johnson of the cancer risks posed by its weedkillers.
from Kaiser Health News https://ift.tt/2OzpO… Read More
Powerful Health Care Players Gearing Up To Push Back Against Single-Payer In Case ‘Blue Wave’ Hits HardIndustry players who usually don't work together are bonding over the potential push for a single-payer system, which has become a litmus test among progressive Democrats.
from Kaiser Health News https://ift.tt/2MHBeC7
… Read More
Technology To ‘Turn Off’ Genes Responsible For Trans Fats Exists. But Is It Ready For Prime-Time?When it comes to altering genes in the food we eat, some experts want to tread carefully while others want to embrace the healthier food. In other public health news: glaucoma, the human cell atlas, c-sections, empathy, famil… Read More
First Gene-Silencing Drug Approved By FDA — And It Comes With An Eye-Popping Price TagSlicing genes with drugs is the latest in a wave of hot new treatments geared toward fighting diseases in unique ways. But the price on innovation is steep. In other news, the FDA plans to streamline drug safety evaluations a… Read More
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment